News
US FDA lifts clinical hold on PORTOLA phase 2a trial of Kezar Life Sciences for evaluating zetomipzomib to treat autoimmune hepatitis: South San Francisco, California Friday, July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback